Bazemore Robert B

President & CEO at Epizyme, Inc.

Sold, on record
$984k
Dollars the filings state
Form 4 sales
8
Latest Mar 25, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Epizyme, Inc.Plan not stated
    Jun 13 2019

    Sold 2,074 shares at $12.10 ($25k)

    Bazemore Robert B, President & CEO

    Sold 2.4% of holdings ($1.1M position)84,994 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Epizyme, Inc.Plan not stated
    Jan 27 +228 days

    Sold 9,076 shares at $21.82 ($198k)

    Bazemore Robert B, President & CEO

    Sold 9.7% of holdings ($2M position)84,668 shares leftFiling

  3. 3 Form 4 sale Epizyme, Inc.Plan not stated
    Mar 25 +58 days

    Sold 3,285 shares at $15.28 ($50k)

    Bazemore Robert B, President & CEO

    Sold 1.3% of holdings ($3.9M position)254,371 shares leftFiling

  4. 4 Form 4 sale Epizyme, Inc.Unusual
    Jun 18 +85 days

    Sold 20,000 shares at $22.00 ($440k)

    Bazemore Robert B, President & CEO

    Sold 7.6% of holdings ($5.8M position)244,371 shares left6.1x usual sizeFiling

  5. 5 Form 4 sale Epizyme, Inc.Plan not stated
    Jun 26 +8 days

    Sold 4,773 shares at $16.15 ($77k)

    Bazemore Robert B, President & CEO

    Sold 1.9% of holdings ($4.1M position)250,098 shares left0.8x usual sizeFiling

  6. 6 Form 4 sale Epizyme, Inc.Plan not stated
    Jan 25 +213 days

    Sold 6,069 shares at $11.41 ($69k)

    Bazemore Robert B, President & CEO

    Sold 2.4% of holdings ($2.9M position)248,367 shares left1.3x usual sizeFiling

  7. 7 Form 4 sale Epizyme, Inc.Plan not stated
    Feb 4 +10 days

    Sold 3,890 shares at $11.21 ($44k)

    Bazemore Robert B, President & CEO

    Sold 1.2% of holdings ($3.8M position)331,977 shares left0.7x usual sizeFiling

  8. 8 Form 4 sale Epizyme, Inc.Plan not stated
    Mar 25 +49 days

    Sold 10,328 shares at $7.85 ($81k)

    Bazemore Robert B, President & CEO

    Sold 3.1% of holdings ($2.6M position)322,626 shares left2.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Bazemore Robert B
Source
Mar 25, 2021Epizyme, Inc.President & CEOForm 4 sale10,328$81k3.1%Plan not statedSEC
Feb 4, 2021Epizyme, Inc.President & CEOForm 4 sale3,890$44k1.2%Plan not statedSEC
Jan 25, 2021Epizyme, Inc.President & CEOForm 4 sale6,069$69k2.4%Plan not statedSEC
Jun 26, 2020Epizyme, Inc.President & CEOForm 4 sale4,773$77k1.9%Plan not statedSEC
Jun 18, 2020Epizyme, Inc.President & CEOForm 4 sale20,000$440k7.6%UnusualSEC
Mar 25, 2020Epizyme, Inc.President & CEOForm 4 sale3,285$50k1.3%Plan not statedSEC
Jan 27, 2020Epizyme, Inc.President & CEOForm 4 sale9,076$198k9.7%Plan not statedSEC
Jun 13, 2019Epizyme, Inc.President & CEOForm 4 sale2,074$25k2.4%Plan not statedSEC